Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-grade B-cell lymphoma presenting primarily in the bone marrow.
Iwatani K, Takata K, Sato Y, Miyata-Takata T, Iwaki N, Cui W, Sawada-Kitamura S, Sonobe H, Tamura M, Saito K, Miyatani K, Yamasaki R, Yamadori I, Fujii N, Terasaki Y, Maeda Y, Tanimoto M, Nakamura N, Yoshino T. Iwatani K, et al. Among authors: terasaki y. Hum Pathol. 2014 Jul;45(7):1379-87. doi: 10.1016/j.humpath.2014.02.010. Epub 2014 Feb 26. Hum Pathol. 2014. PMID: 24767771 Free article.
Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation.
Takamatsu H, Takezako N, Zheng J, Moorhead M, Carlton VEH, Kong KA, Murata R, Ito S, Miyamoto T, Yokoyama K, Matsue K, Sato T, Kurokawa T, Yagi H, Terasaki Y, Ohata K, Matsumoto M, Yoshida T, Faham M, Nakao S. Takamatsu H, et al. Among authors: terasaki y. Ann Oncol. 2017 Oct 1;28(10):2503-2510. doi: 10.1093/annonc/mdx340. Ann Oncol. 2017. PMID: 28945825 Free PMC article.
A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation.
Takamatsu H, Wee RK, Zaimoku Y, Murata R, Zheng J, Moorhead M, Carlton VEH, Kong KA, Takezako N, Ito S, Miyamoto T, Yokoyama K, Matsue K, Sato T, Kurokawa T, Yagi H, Terasaki Y, Ohata K, Matsumoto M, Yoshida T, Faham M, Nakao S. Takamatsu H, et al. Among authors: terasaki y. Br J Haematol. 2018 Nov;183(4):664-668. doi: 10.1111/bjh.15002. Epub 2017 Dec 22. Br J Haematol. 2018. PMID: 29270982 Free article. Clinical Trial. No abstract available.
Corrigendum to "Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation": [Annals of Oncology 28 (2017):2503-2510].
Takamatsu H, Takezako N, Zheng J, Moorhead M, Carlton VEH, Kong KA, Murata R, Ito S, Miyamoto T, Yokoyama K, Matsue K, Sato T, Kurokawa T, Yagi H, Terasaki Y, Ohata K, Matsumoto M, Yoshida T, Faham M, Nakao S. Takamatsu H, et al. Among authors: terasaki y. Ann Oncol. 2023 Mar;34(3):322. doi: 10.1016/j.annonc.2022.08.004. Epub 2022 Sep 6. Ann Oncol. 2023. PMID: 36075840 Free article. No abstract available.
Prospective therapeutic studies of disseminated extranodal large B-cell lymphoma including intravascular large B-cell lymphoma.
Sakai T, Ueda Y, Yanagisawa H, Arita K, Iwao H, Yamada K, Mizuta S, Kawabata H, Fukushima T, Tai K, Kishi S, Morinaga K, Murakami J, Takamatsu H, Terasaki Y, Yoshio N, Kondo Y, Okumura H, Matano S, Yamaguchi M, Tsutani H, Masaki Y. Sakai T, et al. Among authors: terasaki y. Glob Health Med. 2024 Aug 31;6(4):277-281. doi: 10.35772/ghm.2024.01021. Glob Health Med. 2024. PMID: 39219588 Free PMC article.
224 results